Leilani Tran, - Pharmacist in Perris, CA

Leilani Tran, is a Pharmacist based in Perris, California. Leilani Tran is licensed to practice in California (license number 59666) and her current practice location is 404 E 4th St, Perris, California. She can be reached at her office (for appointments etc.) via phone at (951) 943-1575.

NPI number for Leilani Tran is 1003226952 and her current mailing address is 226 Camino De La Luna, Perris, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1003226952.

Contact Information

Leilani Tran,
404 E 4th St,
Perris, CA 92570-2201
(951) 943-1575
(951) 943-1577

Healthcare Provider's Profile

Full NameLeilani Tran
GenderFemale
SpecialityPharmacist
Location404 E 4th St, Perris, California
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1003226952
  • Provider Enumeration Date: 04/30/2014
  • Last Update Date: 02/02/2015

Medical Identifiers

Medical identifiers for Leilani Tran such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003226952NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 59666 (California)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Leilani Tran is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Leilani Tran,
226 Camino De La Luna,
Perris, CA 92571-2991

Ph: (484) 620-5073
Leilani Tran,
404 E 4th St,
Perris, CA 92570-2201

Ph: (951) 943-1575

News Archive

MAP Pharmaceuticals to present new analyses on LEVADEX from FREEDOM-301 Phase 3 clinical trial

MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT. The presentation will show that the Company's investigational LEVADEX™ orally inhaled migraine therapy was effective irrespective of when it was administered during a migraine cycle.

Longer looks: Autism researcher's legacy; methadone for prisoners

Andrew Wakefield has become one of the most reviled doctors of his generation, blamed directly and indirectly, depending on the accuser, for irresponsibly starting a panic with tragic repercussions: vaccination rates so low that childhood diseases once all but eradicated here —whooping cough and measles, among them — have re-emerged, endangering young lives. And yet here he was in Texas, post-career-apocalypse, calmly discussing his work, and a crowd of around 250 people showed up to listen.

More than half of NHS patients display symptoms of relapse after depression treatments, study finds

A new study has shown that approximately 53 per cent of NHS patients displayed clinical symptoms of depression and anxiety within a year after completing psychological treatments.

Lockheed Martin acquires QTC

Lockheed Martin Corporation has completed its acquisition of QTC Holdings Inc. The company, based in Diamond Bar, Calif., is the largest provider of outsourced medical evaluation services to the U.S. Department of Veterans Affairs (VA), processing more than 450,000 evaluations last year.

Many Huntington's disease patients suffer from weight loss, sleeping problems

An aggregating protein causes many of the symptoms of Huntington's disease, an incurable and frequently fatal brain disorder. Mosaic winner Ahmad Aziz discovered that the abnormal protein also aggregates in the hypothalamus, the part of the brain that regulates the autonomic nervous system and the endocrine system.

Read more News

› Verified 5 days ago


Pharmacist in Perris, CA

Dr. Walanika Lum, PHARMD, RPH, RN
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 17016 Birds Eye Dr, Perris, CA 92570
Phone: 951-888-0443    
Yong Soon Chang, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 404 E 4th St, Perris, CA 92570
Phone: 217-721-3435    
Anthony Ayoub,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1675 N Perris Blvd, Perris, CA 92571
Phone: 951-221-5411    
Dulce Huertero Landazuri, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2055 N Perris Blvd, Perris, CA 92571
Phone: 951-943-8188    
Rohit Dhaka,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 24 S D St, Perris, CA 92570
Phone: 951-722-4383    
Morris Shihhao Lai, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1688 N Perris Blvd, Perris, CA 92571
Phone: 951-943-6868    Fax: 951-943-9265

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.